SCHEMBL16729201

SCHEMBL16729201

CCCOCCON1C(=O)c2ccccc2C1=O

nearest known ligand 0.83

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.83
▸ ALDH1A1 P00352 6/20 0.71
▸ TDP1 Q9NUW8 1/20 0.54
▸ RECQL P46063 1/20 0.51
▸ CYP1A2 P05177 2/20 0.48
▸ MAPT P10636 3/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HTT P42858 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ F2 P00734 1/20 0.41
▸ VDR P11473 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24181345 1.00 GAA (0.83) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL12029057 0.91 GAA (1.00) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL12028883 0.91 GAA (1.00) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL3077457 0.91 GAA (1.00) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL26273265 0.90 GAA (0.83) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL6625137 0.89 GAA (0.69) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL13452773 0.88 GAA (0.79) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL15011529 0.86 GAA (0.83) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL15010734 0.86 GAA (0.83) GAAALDH1A1TDP1RECQLCYP1A2
SCHEMBL22326350 0.85 GAA (0.88) GAAALDH1A1TDP1RECQLCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141624-A1 Anti-CD70 Antibody Drug Conjugates AMBRX, INC. (US) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141624-A1 Anti-CD70 Antibody Drug Conjugates CD74, CD63, CD47 GAA 438/4885ALDH1A1 868/4885TDP1 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback